Singapore: Announcement on the List of Regulatory Fee Revision for Health Products

The Health Sciences Authority (HSA) of Singapore announced regulatory fees revision pertaining to health products including medical devices, to be effective on 1 July 2024.  The HSA continues to absorb the 1% Goods and Services Tax (GST) increment which was implemented on 1 Jan 2023 and 1 Jan 2024, until further notice. The fee increase averages 5% and will be capped at $200. The last fee revision happened 2 years ago.

With this announcement, medical device providers are advised to consider new fees for new medical device applications, annual retention, dealer’s license renewal, and pre-market consultation with the HSA in Singapore.

Further information on the announcement can be accessed here.

If you have any queries about this announcement, please do not hesitate to contact us at or click the button below.

Sign up for our regulatory roundup delivered once a month to your inbox

Scroll to Top

Contact Us